(untitled)
A. John Rush(The University of Texas Southwestern Medical Center), R. Hamish McAllister‐Williams(Cumbria Northumberland Tyne and Wear NHS Foundation Trust), Maxine Dibué(LivaNova (United Kingdom)), Koen Demyttenaere(University Psychiatric Hospital), Charles R. Conway(John Cochran VA Medical Center), Allan H. Young(King's College London), Steven D. Hollon(Vanderbilt University), Michael E. Thase(Veterans Health Administration), Mark Bunker(LivaNova (United States)), Scott T. Aaronson(University of Maryland, Baltimore), Harold A. Sackeïm(Medical University of South Carolina)
Newcastle University ePrints (Newcastle Univesity)
January 1, 2000
Cited by 75
Related Papers
The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
|Biological Psychiatry|2003|3.9k
A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression
|New England Journal of Medicine|2000|1.3k
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder
|Nature Genetics|2008|1.3k
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design
|Controlled Clinical Trials|2004|1.1k
Frontiers of cognitive therapy
|General Hospital Psychiatry|1997|1.1k